Article
Regulation of the Type I-F CRISPR-Cas system by CRP-cAMP and GalM controls spacer acquisition and interference.
Nucleic acids research - 13 Jul 2015
Patterson Adrian G, Chang James T, Taylor Corinda, Fineran Peter C
Abstract excerpt
The CRISPR-Cas prokaryotic 'adaptive immune systems' represent a sophisticated defence strategy providing bacteria and archaea with protection from invading genetic elements, such as bacteriophages or plasmids. Despite intensive research into their mechanism and application, how CRISPR-Cas systems are regulated is less clear, and nothing is known about the regulation of Type I-F systems. We used Pectobacterium...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
